Dr. Thuy Le is an Associate Professor of Medicine, Associate Professor of Molecular Genetics and Microbiology at Duke University School of Medicine, co-Director of the Clinical Core of the Duke Center for AIDS Research, and Co-Director of the Tropical Medicine Research Program for Talaromycosis in Vietnam.  She leads an international research collaboration to develop and test novel non-culture-based diagnostics and novel therapeutic strategies for talaromycosis, a severe HIV-associated fungal infection endemic in Southeast Asia. She led the first-ever multi-center treatment trial that has defined international and US treatment guidelines for talaromycosis, and she is currently leading as PI multiple NIH grants to advance a pipeline of novel non-culture diagnostics for talaromycosis. Her passion in the translation of knowledge and technologies into real-world disease control and prevention strategies has placed her at the forefront of national and international leadership in the fields of HIV and Mycology. Dr. Le is a member of multiple WHO Guidelines Committees on HIV Therapy, Management of Advanced HIV Disease, and Management of AIDS-associated Cryptococcal Meningitis and Histoplasmosis. She leads the European Confederation of Medical Mycology Guidelines for Endemic Mycoses and leads the talaromycosis section of the NIH/CDC/HIVMA/IDSA Guidelines on Opportunistic Infections. Dr. Le is a member of the Organizing Committee for the Asia Pacific AIDS and Coinfection Conference. She is an Associate Editor of Medical Mycology and PLOS Neglected Tropical Diseases and has led publications in the New England Journal of Medicine, Lancet, Lancet Infectious Diseases, Lancet Global Health, Clinical Infectious Diseases, AIDS, and Antiviral Therapy.